Abbott Laboratories Inc., already among the most diversified major medtech companies, is now entering the electrophysiology space. With the acquisition of Topera Medical Inc. and the rights to buy Advanced Cardiac Therapeutics Inc., Abbott is going after the rapidly growing, but highly competitive atrial fibrillation catheter ablation market.
Abbott has agreed to acquire all outstanding equity of San Diego-based Topera for $250 million upfront, plus potential future milestones,...